<em class="pub-author">EMCDDA,</em>
<em class="pub-local">Lisbon,</em>
<em class="pub-date"><span class="date-display-single" property="dc:date" datatype="xsd:dateTime" content="2020-11-13T00:00:00+00:00">November 2020</span></em>
<div class="summary">
<h2 class="publications-summary">Summary</h2>
<div class="field field-name-field-summary field-type-text-long field-label-hidden"><div class="field-items" readability="10.5"><div class="field-item even" readability="16">This publication presents the data and findings of the risk assessment on <em>N,N</em>-diethyl-2-[[4-(1-methylethoxy)phenyl]methyl]-5-nitro-1<em>H</em>-benzimidazole-1- ethanamine (isotonitazene), carried out by the extended Scientific Committee of the EMCDDA on 26 May 2020. On the basis of the Risk Assessment Report, on 2 September 2020, the Commission decided that isotonitazene should be included in the definition of 'drug', in the Annex to Framework Decision 2004/757/JHA. Member States shall bring into force the laws, regulations and administrative provisions necessary to comply with Commission Delegated Directive (EU) 2020/1687 by 3 June 2021.
Verslag oor die risikobepaling van N,N-diëtiel-2-[[4-(1-metieletoksi)feniel]metiel]-5-nitro-1Hbenzimidasool-1-etanamien (isotonitaseen) ooreenkomstig Artikel 5c van Regulasie (EG) No 1920/2006 (soos gewysig)
![Verslag oor die risikobepaling van N,N-diëtiel-2-[[4-(1-metieletoksi)feniel]metiel]-5-nitro-1Hbenzimidasool-1-etanamien (isotonitaseen) ooreenkomstig Artikel 5c van Regulasie (EG) No 1920/2006 (soos gewysig)](https://i2.wp.com/www.emcdda.europa.eu/sites/default/files/styles/publication_cover_140x200/public/publication_covers/Screen%20Shot%202020-04-28%20at%2014.38.47.png?itok=0NIziUXp&w=1068&resize=1068,0&ssl=1 "Verslag oor die risikobepaling van N,N-diëtiel-2-[[4-(1-metieletoksi)feniel]metiel]-5-nitro-1Hbenzimidasool-1-etanamien (isotonitaseen) ooreenkomstig Artikel 5c van Regulasie (EG) No 1920/2006 (soos gewysig)")
VRYWARING: Inligting en menings wat in die artikels weergegee word, is dié van diegene wat dit vermeld en dit is hul eie verantwoordelikheid. Publikasie in The European Times beteken nie outomaties onderskrywing van die siening nie, maar die reg om dit uit te druk.
VRYWARINGVERTALINGS: Alle artikels op hierdie webwerf word in Engels gepubliseer. Die vertaalde weergawes word gedoen deur 'n outomatiese proses bekend as neurale vertalings. As jy twyfel, verwys altyd na die oorspronklike artikel. Dankie vir die begrip.
<div class="publication-attachments pdf">
<strong>Download as PDF</strong> </div>
<div>
<div class="publication-toc"><h2>Table of contents</h2><ul><li>Statement regarding the United Kingdom</li>
<li>Foreword</li>
<li>EMCDDA Initial Report on isotonitazene</li>
<li>Risk Assessment Report on a new psychoactive substance: isotonitazene</li>
<li>Technical report on isotonitazene</li>
<li>Participants of the risk assessment meeting, 26 May 2020</li>
<div class="main-subject"><h3 class="field-label"><i class="fa fa-tag"/> Main subject: </h3><p class="field-items"><span class="field-item">NPS</span></p></div>
- Advertensie -
Meer van die skrywer
- EKSKLUSIEWE INHOUD -
- Advertensie -
